T1	PROC 1055 1083	asignados en forma aleatoria
#1	AnnotatorNotes T1	C0034656; Randomization; Research Activity
T2	DISO 280 304	hiponatremia iatrogénica
T3	CHEM 348 353	sodio
#2	AnnotatorNotes T3	C0037473; sodium; Biologically Active Substance · Element, Ion, or Isotope
T4	ANAT 354 360	sérico
#3	AnnotatorNotes T4	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T5	CHEM 446 450	NaCl
#4	AnnotatorNotes T5	C0037494; sodium chloride; Inorganic Chemical
T6	CHEM 462 470	dextrosa
#5	AnnotatorNotes T6	C0017725; glucose; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T7	CHEM 539 543	NaCl
#6	AnnotatorNotes T7	C0037494; sodium chloride; Inorganic Chemical
T8	CHEM 556 564	dextrosa
#7	AnnotatorNotes T8	C0017725; glucose; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T9	ANAT 864 870	sérica
#8	AnnotatorNotes T9	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T10	CHEM 874 876	Na
#9	AnnotatorNotes T10	C0037473; sodium; Biologically Active Substance · Element, Ion, or Isotope
T11	DISO 1730 1742	hiponatremia
#10	AnnotatorNotes T11	C0020625; Hyponatremia; Disease or Syndrome
T12	DISO 1871 1895	hiponatremia iatrogénica
T13	PROC 1 28	Ensayo clínico aleatorizado
#11	AnnotatorNotes T13	C0206034; Clinical Trials, Randomized; Research Activity
T14	PROC 38 52	administración
#12	AnnotatorNotes T14	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T15	CHEM 60 97	solución de mantenimiento intravenosa
T16	CHEM 221 243	soluciones hipotónicas
#13	AnnotatorNotes T16	C0020677; Hypotonic Solutions; Pharmacologic Substance
T17	PROC 348 360	sodio sérico
#14	AnnotatorNotes T17	C0523891; Serum sodium measurement; Laboratory Procedure
T18	PROC 375 389	administración
#15	AnnotatorNotes T18	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T19	CHEM 397 434	solución de mantenimiento intravenosa
T20	CHEM 501 526	solución de mantenimiento
T21	PROC 594 647	Ensayo clínico aleatorizado, doble ciego y controlado
#16	AnnotatorNotes T21	C0013072; Double-Blind Method; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T22	PROC 850 876	concentración sérica de Na
#17	AnnotatorNotes T22	C0523891; Serum sodium measurement; Laboratory Procedure
T23	CHEM 906 931	solución de mantenimiento
T24	PROC 948 962	administración
#18	AnnotatorNotes T24	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T25	CHEM 1098 1123	solución de mantenimiento
T26	CHEM 1276 1284	solución
#19	AnnotatorNotes T26	C0525069; Pharmaceutical Solutions; Biomedical or Dental Material
T27	PROC 1385 1393	infusión
#20	AnnotatorNotes T27	C0574032; Infusion procedures; Therapeutic or Preventive Procedure
T28	PROC 1526 1540	administración
#21	AnnotatorNotes T28	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T29	CHEM 1548 1575	soluciones de mantenimiento
T30	CHEM 1681 1708	soluciones de mantenimiento
T31	PROC 1744 1746	Na
#22	AnnotatorNotes T31	C0337443; Sodium measurement; Laboratory Procedure
T32	CHEM 1781 1808	soluciones de mantenimiento
T33	PROC 1825 1833	infusión
#23	AnnotatorNotes T33	C0574032; Infusion procedures; Therapeutic or Preventive Procedure
T34	Form 60 68	solución
#24	AnnotatorNotes T34	C1382100; Solution Dosage Form; Biomedical or Dental Material
T35	Route 86 97	intravenosa
#25	AnnotatorNotes T35	C1522726; Intravenous Route of Drug Administration; Functional Concept
T36	LIVB 143 173	pacientes pediátricos críticos
#26	AnnotatorNotes T36	C0030705; Patients; Patient or Disabled Group + C0815272; critical population; Population Group + C0008059; Child; Age Group
T37	Form 221 231	soluciones
#27	AnnotatorNotes T37	C1382100; Solution Dosage Form; Biomedical or Dental Material
T38	Form 397 405	solución
#28	AnnotatorNotes T38	C1382100; Solution Dosage Form; Biomedical or Dental Material
T39	Route 423 434	intravenosa
#29	AnnotatorNotes T39	C1522726; Intravenous Route of Drug Administration; Functional Concept
T40	Dose 451 458	al 0,9%
T41	Dose 471 476	al 5%
T42	Form 501 509	solución
#30	AnnotatorNotes T42	C1382100; Solution Dosage Form; Biomedical or Dental Material
T43	Dose 544 552	al 0,45%
T44	Dose 565 570	al 5%
T45	LIVB 662 683	pacientes pediátricos
#31	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group + C0008059; Child; Age Group
T46	Duration 745 762	mayor de 24 horas
T47	Route 786 798	intravenosos
#32	AnnotatorNotes T47	C1522726; Intravenous Route of Drug Administration; Functional Concept
T48	Form 906 914	solución
#33	AnnotatorNotes T48	C1382100; Solution Dosage Form; Biomedical or Dental Material
T49	LIVB 1033 1042	pacientes
#34	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	Form 1098 1106	solución
#35	AnnotatorNotes T50	C1382100; Solution Dosage Form; Biomedical or Dental Material
T56	Duration 1413 1428	24 ± 10,8 horas
T57	Duration 1447 1464	27,6 ± 12,8 horas
T58	Form 1548 1558	soluciones
#36	AnnotatorNotes T58	C1382100; Solution Dosage Form; Biomedical or Dental Material
T62	Form 1681 1691	soluciones
#37	AnnotatorNotes T62	C1382100; Solution Dosage Form; Biomedical or Dental Material
T63	Spec_cue 1720 1729	riesgo de
T65	Form 1781 1791	soluciones
#38	AnnotatorNotes T65	C1382100; Solution Dosage Form; Biomedical or Dental Material
T66	Duration 1813 1821	24 horas
T69	Spec_cue 1852 1861	riesgo de
A1	Population_data T36 Age
A2	Population_data T45 Age
A3	Assertion T11 Speculated
A4	Assertion T12 Speculated
T51	Neg_cue 1835 1837	no
R1	Speculation Arg1:T69 Arg2:T12	
T52	CONC 1838 1848	aumentaron
A5	Assertion T52 Negated
#39	AnnotatorNotes T52	C0442805; Increase; Functional Concept
R2	Negation Arg1:T51 Arg2:T52	
T53	Neg_cue 1226 1228	No
T54	CONC 1234 1245	diferencias
A6	Assertion T54 Negated
#40	AnnotatorNotes T54	C1705241; Delta (difference); Quantitative Concept
R3	Negation Arg1:T53 Arg2:T54	
T55	Neg_cue 1662 1669	Ninguna
T59	CONC 1709 1716	aumentó
A7	Assertion T59 Negated
#41	AnnotatorNotes T59	C0205217; Increased; Quantitative Concept
R4	Negation Arg1:T55 Arg2:T59	
R5	Speculation Arg1:T63 Arg2:T11	
R6	Has_Drug_Form Arg1:T15 Arg2:T34	
R7	Has_Route_or_Mode Arg1:T15 Arg2:T35	
R8	Used_for Arg1:T15 Arg2:T14	
T60	Quantifier_or_Qualifier 130 139	isotónica
R9	Experiences Arg1:T36 Arg2:T14	
T61	Quantifier_or_Qualifier 98 108	hipotónica
R10	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T61	
R11	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T60	
R12	Has_Drug_Form Arg1:T16 Arg2:T37	
T64	Quantifier_or_Qualifier 435 444	isotónica
R14	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T64	
R15	Has_Dose_or_Strength Arg1:T5 Arg2:T40	
R16	Combined_with Arg1:T5 Arg2:T6	
R17	Has_Dose_or_Strength Arg1:T6 Arg2:T41	
R18	Has_Drug_Form Arg1:T20 Arg2:T42	
T67	Quantifier_or_Qualifier 1621 1630	isotónico
T68	Quantifier_or_Qualifier 1583 1593	hipotónico
T70	Quantifier_or_Qualifier 1305 1315	hipotónico
T71	Quantifier_or_Qualifier 1336 1345	isotónico
T72	Quantifier_or_Qualifier 1145 1154	isotónica
T73	Quantifier_or_Qualifier 1124 1134	hipotónica
R19	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T73	
R20	Has_Drug_Form Arg1:T25 Arg2:T50	
R21	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T72	
R22	Experiences Arg1:T49 Arg2:T25	
R23	Location_of Arg1:T9 Arg2:T22	
T74	Quantifier_or_Qualifier 527 537	hipotónica
R24	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T74	
R25	Has_Dose_or_Strength Arg1:T7 Arg2:T43	
R26	Combined_with Arg1:T7 Arg2:T8	
R27	Has_Dose_or_Strength Arg1:T8 Arg2:T44	
R28	Used_for Arg1:T19 Arg2:T18	
R29	Used_for Arg1:T20 Arg2:T18	
R30	Has_Drug_Form Arg1:T19 Arg2:T38	
R31	Location_of Arg1:T4 Arg2:T17	
R32	After Arg1:T17 Arg2:T18	
T75	PROC 692 699;709 744	estadía en la unidad de cuidados intensivos
#42	AnnotatorNotes T75	C5419131; Intensive Care Unit Stay; Health Care Activity
R33	Has_Duration_or_Interval Arg1:T75 Arg2:T46	
T76	PROC 362 365	NaS
#43	AnnotatorNotes T76	C0523891; Serum sodium measurement; Laboratory Procedure
T77	PROC 764 767	NaS
#44	AnnotatorNotes T77	C0523891; Serum sodium measurement; Laboratory Procedure
T78	PROC 1510 1513	NaS
#45	AnnotatorNotes T78	C0523891; Serum sodium measurement; Laboratory Procedure
R34	After Arg1:T76 Arg2:T18	
T79	Result_or_Value 768 774	normal
#46	AnnotatorNotes T79	C0459422; Normal result; Finding | C0586624; Normal laboratory finding; Finding
R35	Has_Result_or_Value Arg1:T77 Arg2:T79	
T80	Observation 777 828	líquidos intravenosos > 80% de los líquidos totales
R36	Before Arg1:T22 Arg2:T23	
R37	Has_Drug_Form Arg1:T23 Arg2:T48	
T81	Result_or_Value 973 988	< 80% del total
R38	Has_Result_or_Value Arg1:T24 Arg2:T81	
R39	Used_for Arg1:T23 Arg2:T24	
R40	Overlap Arg1:T22 Arg2:T24	
R41	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T70	
R42	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T71	
R43	Has_Duration_or_Interval Arg1:T27 Arg2:T56	
T82	Quantifier_or_Qualifier 1401 1411	hipotónico
T83	Quantifier_or_Qualifier 1436 1445	isotónico
R44	Has_Duration_or_Interval Arg1:T27 Arg2:T57	
R45	After Arg1:T78 Arg2:T28	
R46	Has_Drug_Form Arg1:T29 Arg2:T58	
R47	Used_for Arg1:T29 Arg2:T28	
R48	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T68	
R49	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T67	
R50	Has_Drug_Form Arg1:T30 Arg2:T62	
R52	Before Arg1:T30 Arg2:T11	
R54	Has_Drug_Form Arg1:T32 Arg2:T65	
R55	Has_Duration_or_Interval Arg1:T32 Arg2:T66	
R56	Used_for Arg1:T32 Arg2:T33	
R58	Before Arg1:T32 Arg2:T12	
R59	Used_for Arg1:T26 Arg2:T27	
T84	CONC 1168 1191	características basales
#47	AnnotatorNotes T84	C4684572; Baseline Characteristics; Qualitative Concept
A8	Experiencer T36 Patient
A9	Experiencer T45 Patient
A10	Experiencer T49 Patient
